nodes	percent_of_prediction	percent_of_DWPC	metapath
Mefloquine—ACHE—Physostigmine—glaucoma	0.144	0.204	CbGbCtD
Mefloquine—ACHE—Echothiophate—glaucoma	0.144	0.204	CbGbCtD
Mefloquine—ACHE—Dipivefrin—glaucoma	0.0873	0.124	CbGbCtD
Mefloquine—BCHE—Physostigmine—glaucoma	0.0868	0.123	CbGbCtD
Mefloquine—BCHE—Echothiophate—glaucoma	0.0868	0.123	CbGbCtD
Mefloquine—BCHE—Dipivefrin—glaucoma	0.0526	0.0745	CbGbCtD
Mefloquine—CYP2D6—Carteolol—glaucoma	0.0177	0.025	CbGbCtD
Mefloquine—CYP2D6—Betaxolol—glaucoma	0.0119	0.0169	CbGbCtD
Mefloquine—CYP2D6—Methazolamide—glaucoma	0.00904	0.0128	CbGbCtD
Mefloquine—CYP3A4—Pilocarpine—glaucoma	0.00851	0.0121	CbGbCtD
Mefloquine—ABCB1—Timolol—glaucoma	0.00816	0.0116	CbGbCtD
Mefloquine—CYP2D6—Timolol—glaucoma	0.00769	0.0109	CbGbCtD
Mefloquine—ABCB1—Clonidine—glaucoma	0.00694	0.00982	CbGbCtD
Mefloquine—CYP3A4—Brinzolamide—glaucoma	0.00668	0.00946	CbGbCtD
Mefloquine—CYP2D6—Clonidine—glaucoma	0.00653	0.00926	CbGbCtD
Mefloquine—CYP3A4—Dorzolamide—glaucoma	0.00645	0.00913	CbGbCtD
Mefloquine—CYP3A4—Methazolamide—glaucoma	0.00575	0.00814	CbGbCtD
Mefloquine—CYP3A4—Acetazolamide—glaucoma	0.00459	0.00651	CbGbCtD
Mefloquine—CYP3A4—Clonidine—glaucoma	0.00416	0.00589	CbGbCtD
Mefloquine—HBA2—endothelium—glaucoma	0.00359	0.271	CbGeAlD
Mefloquine—HBA1—eye—glaucoma	0.00192	0.145	CbGeAlD
Mefloquine—HBA1—connective tissue—glaucoma	0.00185	0.139	CbGeAlD
Mefloquine—HBA2—eye—glaucoma	0.00176	0.133	CbGeAlD
Mefloquine—HBA2—retina—glaucoma	0.00175	0.132	CbGeAlD
Mefloquine—HBA2—connective tissue—glaucoma	0.0017	0.128	CbGeAlD
Mefloquine—CYP19A1—connective tissue—glaucoma	0.000518	0.039	CbGeAlD
Mefloquine—ABCB1—retina—glaucoma	0.000183	0.0138	CbGeAlD
Mefloquine—Tinnitus—Betaxolol—glaucoma	0.000157	0.00093	CcSEcCtD
Mefloquine—Musculoskeletal discomfort—Pilocarpine—glaucoma	0.000157	0.000928	CcSEcCtD
Mefloquine—Gastrointestinal disorder—Travoprost—glaucoma	0.000157	0.000927	CcSEcCtD
Mefloquine—Fatigue—Travoprost—glaucoma	0.000157	0.000926	CcSEcCtD
Mefloquine—Flushing—Betaxolol—glaucoma	0.000157	0.000925	CcSEcCtD
Mefloquine—Cardiac disorder—Betaxolol—glaucoma	0.000157	0.000925	CcSEcCtD
Mefloquine—Ill-defined disorder—Clonidine—glaucoma	0.000157	0.000925	CcSEcCtD
Mefloquine—Insomnia—Pilocarpine—glaucoma	0.000156	0.000922	CcSEcCtD
Mefloquine—Decreased appetite—Brinzolamide—glaucoma	0.000156	0.000922	CcSEcCtD
Mefloquine—Agitation—Clonidine—glaucoma	0.000155	0.000916	CcSEcCtD
Mefloquine—Gastrointestinal disorder—Brinzolamide—glaucoma	0.000155	0.000915	CcSEcCtD
Mefloquine—Paraesthesia—Pilocarpine—glaucoma	0.000155	0.000915	CcSEcCtD
Mefloquine—Asthenia—Bimatoprost—glaucoma	0.000155	0.000915	CcSEcCtD
Mefloquine—Fatigue—Brinzolamide—glaucoma	0.000155	0.000914	CcSEcCtD
Mefloquine—Dyspnoea—Pilocarpine—glaucoma	0.000154	0.000909	CcSEcCtD
Mefloquine—Somnolence—Pilocarpine—glaucoma	0.000153	0.000906	CcSEcCtD
Mefloquine—Angiopathy—Betaxolol—glaucoma	0.000153	0.000905	CcSEcCtD
Mefloquine—Pruritus—Bimatoprost—glaucoma	0.000153	0.000902	CcSEcCtD
Mefloquine—Diarrhoea—Apraclonidine—glaucoma	0.000152	0.0009	CcSEcCtD
Mefloquine—Malaise—Clonidine—glaucoma	0.000152	0.000899	CcSEcCtD
Mefloquine—Mediastinal disorder—Betaxolol—glaucoma	0.000152	0.000899	CcSEcCtD
Mefloquine—Dyspepsia—Pilocarpine—glaucoma	0.000152	0.000897	CcSEcCtD
Mefloquine—Chills—Betaxolol—glaucoma	0.000151	0.000895	CcSEcCtD
Mefloquine—Syncope—Clonidine—glaucoma	0.000151	0.000894	CcSEcCtD
Mefloquine—Feeling abnormal—Dorzolamide—glaucoma	0.00015	0.000889	CcSEcCtD
Mefloquine—Decreased appetite—Pilocarpine—glaucoma	0.00015	0.000886	CcSEcCtD
Mefloquine—Feeling abnormal—Travoprost—glaucoma	0.00015	0.000885	CcSEcCtD
Mefloquine—Gastrointestinal pain—Dorzolamide—glaucoma	0.000149	0.000882	CcSEcCtD
Mefloquine—Alopecia—Betaxolol—glaucoma	0.000149	0.000881	CcSEcCtD
Mefloquine—Palpitations—Clonidine—glaucoma	0.000149	0.000881	CcSEcCtD
Mefloquine—Gastrointestinal disorder—Pilocarpine—glaucoma	0.000149	0.00088	CcSEcCtD
Mefloquine—Gastrointestinal pain—Travoprost—glaucoma	0.000149	0.000878	CcSEcCtD
Mefloquine—Loss of consciousness—Clonidine—glaucoma	0.000148	0.000876	CcSEcCtD
Mefloquine—Feeling abnormal—Brinzolamide—glaucoma	0.000148	0.000874	CcSEcCtD
Mefloquine—Mental disorder—Betaxolol—glaucoma	0.000148	0.000874	CcSEcCtD
Mefloquine—Sweating—Timolol—glaucoma	0.000147	0.00087	CcSEcCtD
Mefloquine—Dizziness—Apraclonidine—glaucoma	0.000147	0.00087	CcSEcCtD
Mefloquine—Erythema—Betaxolol—glaucoma	0.000147	0.000868	CcSEcCtD
Mefloquine—Malnutrition—Betaxolol—glaucoma	0.000147	0.000868	CcSEcCtD
Mefloquine—Urticaria—Dorzolamide—glaucoma	0.000145	0.000857	CcSEcCtD
Mefloquine—Body temperature increased—Dorzolamide—glaucoma	0.000144	0.000853	CcSEcCtD
Mefloquine—Abdominal pain—Dorzolamide—glaucoma	0.000144	0.000853	CcSEcCtD
Mefloquine—Chest pain—Clonidine—glaucoma	0.000144	0.000849	CcSEcCtD
Mefloquine—Arthralgia—Clonidine—glaucoma	0.000144	0.000849	CcSEcCtD
Mefloquine—Abdominal pain—Travoprost—glaucoma	0.000144	0.000849	CcSEcCtD
Mefloquine—Agranulocytosis—Timolol—glaucoma	0.000143	0.000847	CcSEcCtD
Mefloquine—Anxiety—Clonidine—glaucoma	0.000143	0.000846	CcSEcCtD
Mefloquine—Asthenia—Acetazolamide—glaucoma	0.000143	0.000844	CcSEcCtD
Mefloquine—Dizziness—Bimatoprost—glaucoma	0.000143	0.000843	CcSEcCtD
Mefloquine—Unspecified disorder of skin and subcutaneous tissue—Clonidine—glaucoma	0.000143	0.000843	CcSEcCtD
Mefloquine—Urticaria—Brinzolamide—glaucoma	0.000143	0.000842	CcSEcCtD
Mefloquine—Feeling abnormal—Pilocarpine—glaucoma	0.000142	0.00084	CcSEcCtD
Mefloquine—Discomfort—Clonidine—glaucoma	0.000142	0.000839	CcSEcCtD
Mefloquine—Vomiting—Apraclonidine—glaucoma	0.000142	0.000836	CcSEcCtD
Mefloquine—Muscle spasms—Betaxolol—glaucoma	0.000141	0.000835	CcSEcCtD
Mefloquine—Gastrointestinal pain—Pilocarpine—glaucoma	0.000141	0.000833	CcSEcCtD
Mefloquine—Hypersensitivity—Brimonidine—glaucoma	0.000141	0.000832	CcSEcCtD
Mefloquine—Bradycardia—Timolol—glaucoma	0.00014	0.000829	CcSEcCtD
Mefloquine—Dermatitis—Apraclonidine—glaucoma	0.00014	0.000829	CcSEcCtD
Mefloquine—Headache—Apraclonidine—glaucoma	0.000139	0.000824	CcSEcCtD
Mefloquine—Confusional state—Clonidine—glaucoma	0.000139	0.000821	CcSEcCtD
Mefloquine—Vision blurred—Betaxolol—glaucoma	0.000138	0.000818	CcSEcCtD
Mefloquine—Oedema—Clonidine—glaucoma	0.000138	0.000814	CcSEcCtD
Mefloquine—Tremor—Betaxolol—glaucoma	0.000138	0.000813	CcSEcCtD
Mefloquine—Hallucination—Timolol—glaucoma	0.000137	0.000811	CcSEcCtD
Mefloquine—Asthenia—Brimonidine—glaucoma	0.000137	0.00081	CcSEcCtD
Mefloquine—Abdominal pain—Pilocarpine—glaucoma	0.000136	0.000806	CcSEcCtD
Mefloquine—Body temperature increased—Pilocarpine—glaucoma	0.000136	0.000806	CcSEcCtD
Mefloquine—Ill-defined disorder—Betaxolol—glaucoma	0.000136	0.000805	CcSEcCtD
Mefloquine—Diarrhoea—Acetazolamide—glaucoma	0.000136	0.000805	CcSEcCtD
Mefloquine—Rash—Bimatoprost—glaucoma	0.000136	0.000804	CcSEcCtD
Mefloquine—Dermatitis—Bimatoprost—glaucoma	0.000136	0.000803	CcSEcCtD
Mefloquine—Shock—Clonidine—glaucoma	0.000136	0.000801	CcSEcCtD
Mefloquine—Connective tissue disorder—Timolol—glaucoma	0.000136	0.000801	CcSEcCtD
Mefloquine—Pruritus—Brimonidine—glaucoma	0.000135	0.000799	CcSEcCtD
Mefloquine—Headache—Bimatoprost—glaucoma	0.000135	0.000799	CcSEcCtD
Mefloquine—Nervous system disorder—Clonidine—glaucoma	0.000135	0.000798	CcSEcCtD
Mefloquine—Thrombocytopenia—Clonidine—glaucoma	0.000135	0.000797	CcSEcCtD
Mefloquine—Hypersensitivity—Dorzolamide—glaucoma	0.000134	0.000795	CcSEcCtD
Mefloquine—Tachycardia—Clonidine—glaucoma	0.000134	0.000794	CcSEcCtD
Mefloquine—Hypersensitivity—Travoprost—glaucoma	0.000134	0.000791	CcSEcCtD
Mefloquine—Skin disorder—Clonidine—glaucoma	0.000134	0.00079	CcSEcCtD
Mefloquine—Hyperhidrosis—Clonidine—glaucoma	0.000133	0.000787	CcSEcCtD
Mefloquine—Visual impairment—Timolol—glaucoma	0.000133	0.000785	CcSEcCtD
Mefloquine—Malaise—Betaxolol—glaucoma	0.000133	0.000783	CcSEcCtD
Mefloquine—Nausea—Apraclonidine—glaucoma	0.000132	0.000781	CcSEcCtD
Mefloquine—Hypersensitivity—Brinzolamide—glaucoma	0.000132	0.000781	CcSEcCtD
Mefloquine—Vertigo—Betaxolol—glaucoma	0.000132	0.00078	CcSEcCtD
Mefloquine—Syncope—Betaxolol—glaucoma	0.000132	0.000778	CcSEcCtD
Mefloquine—Dizziness—Acetazolamide—glaucoma	0.000132	0.000778	CcSEcCtD
Mefloquine—Asthenia—Dorzolamide—glaucoma	0.000131	0.000774	CcSEcCtD
Mefloquine—Asthenia—Travoprost—glaucoma	0.00013	0.00077	CcSEcCtD
Mefloquine—Palpitations—Betaxolol—glaucoma	0.00013	0.000767	CcSEcCtD
Mefloquine—Pruritus—Dorzolamide—glaucoma	0.000129	0.000763	CcSEcCtD
Mefloquine—Loss of consciousness—Betaxolol—glaucoma	0.000129	0.000763	CcSEcCtD
Mefloquine—Eye disorder—Timolol—glaucoma	0.000129	0.000761	CcSEcCtD
Mefloquine—Asthenia—Brinzolamide—glaucoma	0.000129	0.000761	CcSEcCtD
Mefloquine—Hypotension—Clonidine—glaucoma	0.000129	0.00076	CcSEcCtD
Mefloquine—Pruritus—Travoprost—glaucoma	0.000129	0.00076	CcSEcCtD
Mefloquine—Tinnitus—Timolol—glaucoma	0.000129	0.00076	CcSEcCtD
Mefloquine—Nausea—Bimatoprost—glaucoma	0.000128	0.000758	CcSEcCtD
Mefloquine—Cardiac disorder—Timolol—glaucoma	0.000128	0.000756	CcSEcCtD
Mefloquine—Hypersensitivity—Pilocarpine—glaucoma	0.000127	0.000751	CcSEcCtD
Mefloquine—Pruritus—Brinzolamide—glaucoma	0.000127	0.00075	CcSEcCtD
Mefloquine—Vomiting—Acetazolamide—glaucoma	0.000127	0.000748	CcSEcCtD
Mefloquine—Dizziness—Brimonidine—glaucoma	0.000126	0.000747	CcSEcCtD
Mefloquine—Musculoskeletal discomfort—Clonidine—glaucoma	0.000125	0.000741	CcSEcCtD
Mefloquine—Angiopathy—Timolol—glaucoma	0.000125	0.000739	CcSEcCtD
Mefloquine—Myalgia—Betaxolol—glaucoma	0.000125	0.000739	CcSEcCtD
Mefloquine—Chest pain—Betaxolol—glaucoma	0.000125	0.000739	CcSEcCtD
Mefloquine—Arthralgia—Betaxolol—glaucoma	0.000125	0.000739	CcSEcCtD
Mefloquine—Diarrhoea—Dorzolamide—glaucoma	0.000125	0.000738	CcSEcCtD
Mefloquine—Headache—Acetazolamide—glaucoma	0.000125	0.000737	CcSEcCtD
Mefloquine—Anxiety—Betaxolol—glaucoma	0.000125	0.000737	CcSEcCtD
Mefloquine—Insomnia—Clonidine—glaucoma	0.000125	0.000736	CcSEcCtD
Mefloquine—Diarrhoea—Travoprost—glaucoma	0.000124	0.000735	CcSEcCtD
Mefloquine—Mediastinal disorder—Timolol—glaucoma	0.000124	0.000734	CcSEcCtD
Mefloquine—Unspecified disorder of skin and subcutaneous tissue—Betaxolol—glaucoma	0.000124	0.000734	CcSEcCtD
Mefloquine—Asthenia—Pilocarpine—glaucoma	0.000124	0.000731	CcSEcCtD
Mefloquine—Paraesthesia—Clonidine—glaucoma	0.000124	0.000731	CcSEcCtD
Mefloquine—Discomfort—Betaxolol—glaucoma	0.000124	0.00073	CcSEcCtD
Mefloquine—Dyspnoea—Clonidine—glaucoma	0.000123	0.000726	CcSEcCtD
Mefloquine—Diarrhoea—Brinzolamide—glaucoma	0.000123	0.000725	CcSEcCtD
Mefloquine—Somnolence—Clonidine—glaucoma	0.000122	0.000723	CcSEcCtD
Mefloquine—Pruritus—Pilocarpine—glaucoma	0.000122	0.000721	CcSEcCtD
Mefloquine—Alopecia—Timolol—glaucoma	0.000122	0.00072	CcSEcCtD
Mefloquine—Confusional state—Betaxolol—glaucoma	0.000121	0.000714	CcSEcCtD
Mefloquine—Mental disorder—Timolol—glaucoma	0.000121	0.000714	CcSEcCtD
Mefloquine—Dizziness—Dorzolamide—glaucoma	0.000121	0.000713	CcSEcCtD
Mefloquine—Rash—Brimonidine—glaucoma	0.000121	0.000712	CcSEcCtD
Mefloquine—Dermatitis—Brimonidine—glaucoma	0.00012	0.000711	CcSEcCtD
Mefloquine—Dizziness—Travoprost—glaucoma	0.00012	0.00071	CcSEcCtD
Mefloquine—Erythema—Timolol—glaucoma	0.00012	0.000709	CcSEcCtD
Mefloquine—Malnutrition—Timolol—glaucoma	0.00012	0.000709	CcSEcCtD
Mefloquine—Oedema—Betaxolol—glaucoma	0.00012	0.000708	CcSEcCtD
Mefloquine—Headache—Brimonidine—glaucoma	0.00012	0.000707	CcSEcCtD
Mefloquine—Decreased appetite—Clonidine—glaucoma	0.00012	0.000707	CcSEcCtD
Mefloquine—Gastrointestinal disorder—Clonidine—glaucoma	0.000119	0.000703	CcSEcCtD
Mefloquine—Fatigue—Clonidine—glaucoma	0.000119	0.000702	CcSEcCtD
Mefloquine—Dizziness—Brinzolamide—glaucoma	0.000119	0.000701	CcSEcCtD
Mefloquine—Nausea—Acetazolamide—glaucoma	0.000118	0.000699	CcSEcCtD
Mefloquine—Diarrhoea—Pilocarpine—glaucoma	0.000118	0.000697	CcSEcCtD
Mefloquine—Shock—Betaxolol—glaucoma	0.000118	0.000697	CcSEcCtD
Mefloquine—Nervous system disorder—Betaxolol—glaucoma	0.000118	0.000695	CcSEcCtD
Mefloquine—Thrombocytopenia—Betaxolol—glaucoma	0.000117	0.000694	CcSEcCtD
Mefloquine—Tachycardia—Betaxolol—glaucoma	0.000117	0.000691	CcSEcCtD
Mefloquine—Skin disorder—Betaxolol—glaucoma	0.000116	0.000688	CcSEcCtD
Mefloquine—Vomiting—Dorzolamide—glaucoma	0.000116	0.000686	CcSEcCtD
Mefloquine—Hyperhidrosis—Betaxolol—glaucoma	0.000116	0.000685	CcSEcCtD
Mefloquine—Rash—Dorzolamide—glaucoma	0.000115	0.00068	CcSEcCtD
Mefloquine—Dermatitis—Dorzolamide—glaucoma	0.000115	0.000679	CcSEcCtD
Mefloquine—Rash—Travoprost—glaucoma	0.000115	0.000677	CcSEcCtD
Mefloquine—Dermatitis—Travoprost—glaucoma	0.000114	0.000676	CcSEcCtD
Mefloquine—Headache—Dorzolamide—glaucoma	0.000114	0.000676	CcSEcCtD
Mefloquine—Vomiting—Brinzolamide—glaucoma	0.000114	0.000674	CcSEcCtD
Mefloquine—Dizziness—Pilocarpine—glaucoma	0.000114	0.000674	CcSEcCtD
Mefloquine—Headache—Travoprost—glaucoma	0.000114	0.000673	CcSEcCtD
Mefloquine—Nausea—Brimonidine—glaucoma	0.000114	0.000671	CcSEcCtD
Mefloquine—Feeling abnormal—Clonidine—glaucoma	0.000114	0.000671	CcSEcCtD
Mefloquine—Rash—Brinzolamide—glaucoma	0.000113	0.000668	CcSEcCtD
Mefloquine—Vision blurred—Timolol—glaucoma	0.000113	0.000668	CcSEcCtD
Mefloquine—Dermatitis—Brinzolamide—glaucoma	0.000113	0.000668	CcSEcCtD
Mefloquine—Gastrointestinal pain—Clonidine—glaucoma	0.000113	0.000665	CcSEcCtD
Mefloquine—Headache—Brinzolamide—glaucoma	0.000112	0.000664	CcSEcCtD
Mefloquine—Hypotension—Betaxolol—glaucoma	0.000112	0.000662	CcSEcCtD
Mefloquine—Vomiting—Pilocarpine—glaucoma	0.00011	0.000648	CcSEcCtD
Mefloquine—Urticaria—Clonidine—glaucoma	0.000109	0.000646	CcSEcCtD
Mefloquine—Musculoskeletal discomfort—Betaxolol—glaucoma	0.000109	0.000645	CcSEcCtD
Mefloquine—Body temperature increased—Clonidine—glaucoma	0.000109	0.000643	CcSEcCtD
Mefloquine—Abdominal pain—Clonidine—glaucoma	0.000109	0.000643	CcSEcCtD
Mefloquine—Rash—Pilocarpine—glaucoma	0.000109	0.000643	CcSEcCtD
Mefloquine—Dermatitis—Pilocarpine—glaucoma	0.000109	0.000642	CcSEcCtD
Mefloquine—Insomnia—Betaxolol—glaucoma	0.000108	0.000641	CcSEcCtD
Mefloquine—Nausea—Dorzolamide—glaucoma	0.000108	0.000641	CcSEcCtD
Mefloquine—Headache—Pilocarpine—glaucoma	0.000108	0.000638	CcSEcCtD
Mefloquine—Nausea—Travoprost—glaucoma	0.000108	0.000638	CcSEcCtD
Mefloquine—Vertigo—Timolol—glaucoma	0.000108	0.000637	CcSEcCtD
Mefloquine—Paraesthesia—Betaxolol—glaucoma	0.000108	0.000636	CcSEcCtD
Mefloquine—Syncope—Timolol—glaucoma	0.000108	0.000636	CcSEcCtD
Mefloquine—Dyspnoea—Betaxolol—glaucoma	0.000107	0.000632	CcSEcCtD
Mefloquine—Nausea—Brinzolamide—glaucoma	0.000107	0.00063	CcSEcCtD
Mefloquine—Palpitations—Timolol—glaucoma	0.000106	0.000627	CcSEcCtD
Mefloquine—Dyspepsia—Betaxolol—glaucoma	0.000106	0.000624	CcSEcCtD
Mefloquine—Loss of consciousness—Timolol—glaucoma	0.000106	0.000623	CcSEcCtD
Mefloquine—Decreased appetite—Betaxolol—glaucoma	0.000104	0.000616	CcSEcCtD
Mefloquine—Hypertension—Timolol—glaucoma	0.000104	0.000612	CcSEcCtD
Mefloquine—Gastrointestinal disorder—Betaxolol—glaucoma	0.000104	0.000612	CcSEcCtD
Mefloquine—Fatigue—Betaxolol—glaucoma	0.000103	0.000611	CcSEcCtD
Mefloquine—Nausea—Pilocarpine—glaucoma	0.000102	0.000605	CcSEcCtD
Mefloquine—Myalgia—Timolol—glaucoma	0.000102	0.000604	CcSEcCtD
Mefloquine—Chest pain—Timolol—glaucoma	0.000102	0.000604	CcSEcCtD
Mefloquine—Arthralgia—Timolol—glaucoma	0.000102	0.000604	CcSEcCtD
Mefloquine—Anxiety—Timolol—glaucoma	0.000102	0.000602	CcSEcCtD
Mefloquine—Unspecified disorder of skin and subcutaneous tissue—Timolol—glaucoma	0.000101	0.0006	CcSEcCtD
Mefloquine—Hypersensitivity—Clonidine—glaucoma	0.000101	0.0006	CcSEcCtD
Mefloquine—Discomfort—Timolol—glaucoma	0.000101	0.000597	CcSEcCtD
Mefloquine—Asthenia—Clonidine—glaucoma	9.88e-05	0.000584	CcSEcCtD
Mefloquine—Feeling abnormal—Betaxolol—glaucoma	9.88e-05	0.000584	CcSEcCtD
Mefloquine—Confusional state—Timolol—glaucoma	9.88e-05	0.000584	CcSEcCtD
Mefloquine—Anaphylactic shock—Timolol—glaucoma	9.8e-05	0.000579	CcSEcCtD
Mefloquine—Oedema—Timolol—glaucoma	9.8e-05	0.000579	CcSEcCtD
Mefloquine—Pruritus—Clonidine—glaucoma	9.74e-05	0.000576	CcSEcCtD
Mefloquine—Shock—Timolol—glaucoma	9.64e-05	0.000569	CcSEcCtD
Mefloquine—Nervous system disorder—Timolol—glaucoma	9.61e-05	0.000568	CcSEcCtD
Mefloquine—Urticaria—Betaxolol—glaucoma	9.53e-05	0.000563	CcSEcCtD
Mefloquine—Skin disorder—Timolol—glaucoma	9.52e-05	0.000562	CcSEcCtD
Mefloquine—Body temperature increased—Betaxolol—glaucoma	9.48e-05	0.00056	CcSEcCtD
Mefloquine—Hyperhidrosis—Timolol—glaucoma	9.47e-05	0.00056	CcSEcCtD
Mefloquine—Diarrhoea—Clonidine—glaucoma	9.42e-05	0.000557	CcSEcCtD
Mefloquine—Hypotension—Timolol—glaucoma	9.15e-05	0.000541	CcSEcCtD
Mefloquine—Dizziness—Clonidine—glaucoma	9.11e-05	0.000538	CcSEcCtD
Mefloquine—Musculoskeletal discomfort—Timolol—glaucoma	8.93e-05	0.000527	CcSEcCtD
Mefloquine—Insomnia—Timolol—glaucoma	8.86e-05	0.000523	CcSEcCtD
Mefloquine—Hypersensitivity—Betaxolol—glaucoma	8.83e-05	0.000522	CcSEcCtD
Mefloquine—Paraesthesia—Timolol—glaucoma	8.8e-05	0.00052	CcSEcCtD
Mefloquine—Vomiting—Clonidine—glaucoma	8.76e-05	0.000517	CcSEcCtD
Mefloquine—Dyspnoea—Timolol—glaucoma	8.73e-05	0.000516	CcSEcCtD
Mefloquine—Somnolence—Timolol—glaucoma	8.71e-05	0.000515	CcSEcCtD
Mefloquine—Rash—Clonidine—glaucoma	8.68e-05	0.000513	CcSEcCtD
Mefloquine—Dermatitis—Clonidine—glaucoma	8.68e-05	0.000513	CcSEcCtD
Mefloquine—Headache—Clonidine—glaucoma	8.63e-05	0.00051	CcSEcCtD
Mefloquine—Dyspepsia—Timolol—glaucoma	8.62e-05	0.000509	CcSEcCtD
Mefloquine—Asthenia—Betaxolol—glaucoma	8.6e-05	0.000508	CcSEcCtD
Mefloquine—Decreased appetite—Timolol—glaucoma	8.52e-05	0.000503	CcSEcCtD
Mefloquine—Pruritus—Betaxolol—glaucoma	8.48e-05	0.000501	CcSEcCtD
Mefloquine—Gastrointestinal disorder—Timolol—glaucoma	8.46e-05	0.0005	CcSEcCtD
Mefloquine—Fatigue—Timolol—glaucoma	8.45e-05	0.000499	CcSEcCtD
Mefloquine—Diarrhoea—Betaxolol—glaucoma	8.2e-05	0.000485	CcSEcCtD
Mefloquine—Nausea—Clonidine—glaucoma	8.18e-05	0.000483	CcSEcCtD
Mefloquine—Feeling abnormal—Timolol—glaucoma	8.07e-05	0.000477	CcSEcCtD
Mefloquine—Gastrointestinal pain—Timolol—glaucoma	8.01e-05	0.000473	CcSEcCtD
Mefloquine—Dizziness—Betaxolol—glaucoma	7.93e-05	0.000469	CcSEcCtD
Mefloquine—Urticaria—Timolol—glaucoma	7.78e-05	0.00046	CcSEcCtD
Mefloquine—Body temperature increased—Timolol—glaucoma	7.74e-05	0.000458	CcSEcCtD
Mefloquine—Abdominal pain—Timolol—glaucoma	7.74e-05	0.000458	CcSEcCtD
Mefloquine—Vomiting—Betaxolol—glaucoma	7.62e-05	0.00045	CcSEcCtD
Mefloquine—Rash—Betaxolol—glaucoma	7.56e-05	0.000447	CcSEcCtD
Mefloquine—Dermatitis—Betaxolol—glaucoma	7.55e-05	0.000446	CcSEcCtD
Mefloquine—ADORA2A—Signaling by NGF—NGFR—glaucoma	7.53e-05	0.000676	CbGpPWpGaD
Mefloquine—Headache—Betaxolol—glaucoma	7.51e-05	0.000444	CcSEcCtD
Mefloquine—HBA2—Metabolism—MTHFR—glaucoma	7.45e-05	0.000668	CbGpPWpGaD
Mefloquine—ADORA2A—Circadian rythm related genes—FAS—glaucoma	7.44e-05	0.000667	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—NARFL—glaucoma	7.37e-05	0.000661	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—CA5A—glaucoma	7.37e-05	0.000661	CbGpPWpGaD
Mefloquine—ACHE—Integrated Pancreatic Cancer Pathway—CDKN2B—glaucoma	7.28e-05	0.000653	CbGpPWpGaD
Mefloquine—CYP2D6—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	7.25e-05	0.00065	CbGpPWpGaD
Mefloquine—CYP3A4—Tryptophan metabolism—CYP1B1—glaucoma	7.23e-05	0.000649	CbGpPWpGaD
Mefloquine—ACHE—Integrated Pancreatic Cancer Pathway—BDNF—glaucoma	7.23e-05	0.000649	CbGpPWpGaD
Mefloquine—Hypersensitivity—Timolol—glaucoma	7.22e-05	0.000426	CcSEcCtD
Mefloquine—ADORA2A—Signaling by NGF—NTRK1—glaucoma	7.16e-05	0.000642	CbGpPWpGaD
Mefloquine—Nausea—Betaxolol—glaucoma	7.12e-05	0.000421	CcSEcCtD
Mefloquine—ABCB1—HIF-1-alpha transcription factor network—EDN1—glaucoma	7.11e-05	0.000638	CbGpPWpGaD
Mefloquine—Asthenia—Timolol—glaucoma	7.03e-05	0.000415	CcSEcCtD
Mefloquine—ACHE—Metabolism of proteins—ACE2—glaucoma	6.97e-05	0.000626	CbGpPWpGaD
Mefloquine—HBA2—Metabolism—APOE—glaucoma	6.94e-05	0.000622	CbGpPWpGaD
Mefloquine—Pruritus—Timolol—glaucoma	6.93e-05	0.000409	CcSEcCtD
Mefloquine—ADORA2A—Signaling by GPCR—PTGFR—glaucoma	6.92e-05	0.000621	CbGpPWpGaD
Mefloquine—CYP19A1—Biological oxidations—GSTM1—glaucoma	6.9e-05	0.000619	CbGpPWpGaD
Mefloquine—HBA2—Metabolism—CAV1—glaucoma	6.87e-05	0.000616	CbGpPWpGaD
Mefloquine—CYP19A1—Metapathway biotransformation—GSTM1—glaucoma	6.8e-05	0.00061	CbGpPWpGaD
Mefloquine—ADORA2A—GPCR ligand binding—SMO—glaucoma	6.8e-05	0.00061	CbGpPWpGaD
Mefloquine—BCHE—Metabolism of proteins—CTSA—glaucoma	6.76e-05	0.000607	CbGpPWpGaD
Mefloquine—Diarrhoea—Timolol—glaucoma	6.7e-05	0.000396	CcSEcCtD
Mefloquine—ADORA1—Class A/1 (Rhodopsin-like receptors)—C3—glaucoma	6.66e-05	0.000598	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—LRP12—glaucoma	6.55e-05	0.000588	CbGpPWpGaD
Mefloquine—ABCB1—Transmembrane transport of small molecules—PEX19—glaucoma	6.53e-05	0.000585	CbGpPWpGaD
Mefloquine—CYP19A1—Integrated Breast Cancer Pathway—MMP1—glaucoma	6.51e-05	0.000584	CbGpPWpGaD
Mefloquine—Dizziness—Timolol—glaucoma	6.48e-05	0.000383	CcSEcCtD
Mefloquine—HBA1—Metabolism—GSTM1—glaucoma	6.39e-05	0.000573	CbGpPWpGaD
Mefloquine—ADORA2A—NGF signalling via TRKA from the plasma membrane—BAD—glaucoma	6.24e-05	0.00056	CbGpPWpGaD
Mefloquine—Vomiting—Timolol—glaucoma	6.23e-05	0.000368	CcSEcCtD
Mefloquine—BCHE—Metabolism of proteins—ACE2—glaucoma	6.22e-05	0.000558	CbGpPWpGaD
Mefloquine—ACHE—Integrated Pancreatic Cancer Pathway—FAS—glaucoma	6.19e-05	0.000555	CbGpPWpGaD
Mefloquine—Rash—Timolol—glaucoma	6.18e-05	0.000365	CcSEcCtD
Mefloquine—Dermatitis—Timolol—glaucoma	6.17e-05	0.000365	CcSEcCtD
Mefloquine—Headache—Timolol—glaucoma	6.14e-05	0.000363	CcSEcCtD
Mefloquine—ABCB1—Allograft Rejection—IL1A—glaucoma	6.12e-05	0.000549	CbGpPWpGaD
Mefloquine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—EDN1—glaucoma	5.89e-05	0.000528	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—OPN4—glaucoma	5.88e-05	0.000528	CbGpPWpGaD
Mefloquine—CYP19A1—Integrated Breast Cancer Pathway—BAD—glaucoma	5.87e-05	0.000527	CbGpPWpGaD
Mefloquine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	5.85e-05	0.000525	CbGpPWpGaD
Mefloquine—Nausea—Timolol—glaucoma	5.82e-05	0.000344	CcSEcCtD
Mefloquine—ADORA2A—Signaling by NGF—NGF—glaucoma	5.82e-05	0.000522	CbGpPWpGaD
Mefloquine—ADORA1—GPCR ligand binding—EDN1—glaucoma	5.81e-05	0.000521	CbGpPWpGaD
Mefloquine—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—glaucoma	5.77e-05	0.000518	CbGpPWpGaD
Mefloquine—HBA1—Metabolism—MTHFR—glaucoma	5.65e-05	0.000507	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—HEYL—glaucoma	5.47e-05	0.000491	CbGpPWpGaD
Mefloquine—ABCB1—Allograft Rejection—FAS—glaucoma	5.46e-05	0.00049	CbGpPWpGaD
Mefloquine—ABCB1—Allograft Rejection—C3—glaucoma	5.38e-05	0.000483	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—PTGFR—glaucoma	5.3e-05	0.000475	CbGpPWpGaD
Mefloquine—ACHE—Integrated Pancreatic Cancer Pathway—BAD—glaucoma	5.29e-05	0.000475	CbGpPWpGaD
Mefloquine—HBA1—Metabolism—APOE—glaucoma	5.26e-05	0.000472	CbGpPWpGaD
Mefloquine—HBA1—Metabolism—CAV1—glaucoma	5.21e-05	0.000467	CbGpPWpGaD
Mefloquine—HBA2—Metabolism—NOS3—glaucoma	5.2e-05	0.000466	CbGpPWpGaD
Mefloquine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—C3—glaucoma	5.14e-05	0.000462	CbGpPWpGaD
Mefloquine—ADORA1—GPCR ligand binding—C3—glaucoma	5.07e-05	0.000455	CbGpPWpGaD
Mefloquine—CYP2D6—Biological oxidations—GSTT1—glaucoma	4.83e-05	0.000434	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by NGF—BAD—glaucoma	4.8e-05	0.00043	CbGpPWpGaD
Mefloquine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—glaucoma	4.76e-05	0.000427	CbGpPWpGaD
Mefloquine—HBA2—Metabolism—PTGS2—glaucoma	4.75e-05	0.000426	CbGpPWpGaD
Mefloquine—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	4.74e-05	0.000425	CbGpPWpGaD
Mefloquine—ABCB1—Integrated Pancreatic Cancer Pathway—SMO—glaucoma	4.61e-05	0.000414	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—OPN4—glaucoma	4.54e-05	0.000407	CbGpPWpGaD
Mefloquine—ADORA1—Signaling by GPCR—SMO—glaucoma	4.52e-05	0.000406	CbGpPWpGaD
Mefloquine—ADORA2A—GPCR ligand binding—EDN1—glaucoma	4.48e-05	0.000402	CbGpPWpGaD
Mefloquine—ABCB1—Transmembrane transport of small molecules—SLC4A4—glaucoma	4.41e-05	0.000395	CbGpPWpGaD
Mefloquine—ADORA2A—NGF signalling via TRKA from the plasma membrane—CDKN1B—glaucoma	4.34e-05	0.00039	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—HEYL—glaucoma	4.22e-05	0.000379	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—RPTOR—glaucoma	4.14e-05	0.000372	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—PTGFR—glaucoma	4.09e-05	0.000367	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—CA1—glaucoma	4.03e-05	0.000362	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—NCK2—glaucoma	4.01e-05	0.00036	CbGpPWpGaD
Mefloquine—HBA1—Metabolism—NOS3—glaucoma	3.94e-05	0.000353	CbGpPWpGaD
Mefloquine—ADORA2A—GPCR ligand binding—C3—glaucoma	3.92e-05	0.000351	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—CTSA—glaucoma	3.91e-05	0.00035	CbGpPWpGaD
Mefloquine—ACHE—Integrated Pancreatic Cancer Pathway—PTGS2—glaucoma	3.89e-05	0.000349	CbGpPWpGaD
Mefloquine—CYP2D6—Biological oxidations—CYP1B1—glaucoma	3.85e-05	0.000346	CbGpPWpGaD
Mefloquine—CYP2D6—Metapathway biotransformation—CYP1B1—glaucoma	3.8e-05	0.000341	CbGpPWpGaD
Mefloquine—ACHE—Metabolism of proteins—PAX6—glaucoma	3.72e-05	0.000334	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—CA1—glaucoma	3.71e-05	0.000333	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—CA2—glaucoma	3.69e-05	0.000331	CbGpPWpGaD
Mefloquine—ACHE—Integrated Pancreatic Cancer Pathway—CDKN1B—glaucoma	3.69e-05	0.000331	CbGpPWpGaD
Mefloquine—ADORA1—Circadian rythm related genes—TP53—glaucoma	3.61e-05	0.000323	CbGpPWpGaD
Mefloquine—ACHE—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	3.61e-05	0.000323	CbGpPWpGaD
Mefloquine—ACHE—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	3.61e-05	0.000323	CbGpPWpGaD
Mefloquine—HBA1—Metabolism—PTGS2—glaucoma	3.6e-05	0.000323	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—CA1—glaucoma	3.6e-05	0.000323	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—CA5A—glaucoma	3.59e-05	0.000323	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—NARFL—glaucoma	3.59e-05	0.000323	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—CTSA—glaucoma	3.59e-05	0.000322	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by GPCR—SMO—glaucoma	3.49e-05	0.000313	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—CTSA—glaucoma	3.48e-05	0.000313	CbGpPWpGaD
Mefloquine—ABCB1—Integrated Pancreatic Cancer Pathway—NTRK1—glaucoma	3.44e-05	0.000308	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—HDAC9—glaucoma	3.41e-05	0.000306	CbGpPWpGaD
Mefloquine—CYP19A1—Integrated Breast Cancer Pathway—VEGFA—glaucoma	3.4e-05	0.000305	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—CA2—glaucoma	3.39e-05	0.000304	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—CA5A—glaucoma	3.39e-05	0.000304	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—NARFL—glaucoma	3.39e-05	0.000304	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by NGF—CDKN1B—glaucoma	3.34e-05	0.0003	CbGpPWpGaD
Mefloquine—BCHE—Metabolism of proteins—PAX6—glaucoma	3.32e-05	0.000298	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	3.31e-05	0.000297	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	3.31e-05	0.000297	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—CA2—glaucoma	3.29e-05	0.000295	CbGpPWpGaD
Mefloquine—ADORA1—GPCR downstream signaling—EDN1—glaucoma	3.28e-05	0.000294	CbGpPWpGaD
Mefloquine—BCHE—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	3.22e-05	0.000289	CbGpPWpGaD
Mefloquine—BCHE—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	3.22e-05	0.000289	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—RPTOR—glaucoma	3.2e-05	0.000287	CbGpPWpGaD
Mefloquine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN2B—glaucoma	3.17e-05	0.000284	CbGpPWpGaD
Mefloquine—CYP3A4—Biological oxidations—GSTT1—glaucoma	3.16e-05	0.000284	CbGpPWpGaD
Mefloquine—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—glaucoma	3.15e-05	0.000282	CbGpPWpGaD
Mefloquine—ABCB1—HIF-1-alpha transcription factor network—VEGFA—glaucoma	3.12e-05	0.00028	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—NCK2—glaucoma	3.1e-05	0.000278	CbGpPWpGaD
Mefloquine—CYP2D6—Biological oxidations—GSTM1—glaucoma	3.08e-05	0.000276	CbGpPWpGaD
Mefloquine—ACHE—Integrated Pancreatic Cancer Pathway—VEGFA—glaucoma	3.07e-05	0.000275	CbGpPWpGaD
Mefloquine—CYP2D6—Metapathway biotransformation—GSTM1—glaucoma	3.04e-05	0.000272	CbGpPWpGaD
Mefloquine—ADORA1—Signaling by GPCR—EDN1—glaucoma	2.98e-05	0.000267	CbGpPWpGaD
Mefloquine—ABCB1—Transmembrane transport of small molecules—SLC6A13—glaucoma	2.94e-05	0.000264	CbGpPWpGaD
Mefloquine—ADORA1—GPCR downstream signaling—C3—glaucoma	2.87e-05	0.000257	CbGpPWpGaD
Mefloquine—ADORA2A—Circadian rythm related genes—TP53—glaucoma	2.78e-05	0.00025	CbGpPWpGaD
Mefloquine—ABCB1—Allograft Rejection—VEGFA—glaucoma	2.7e-05	0.000243	CbGpPWpGaD
Mefloquine—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—glaucoma	2.69e-05	0.000242	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—SMO—glaucoma	2.67e-05	0.00024	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—HDAC9—glaucoma	2.64e-05	0.000236	CbGpPWpGaD
Mefloquine—ACHE—Integrated Pancreatic Cancer Pathway—TNF—glaucoma	2.63e-05	0.000236	CbGpPWpGaD
Mefloquine—ADORA1—Signaling by GPCR—C3—glaucoma	2.6e-05	0.000234	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—TXN—glaucoma	2.6e-05	0.000233	CbGpPWpGaD
Mefloquine—CYP19A1—Integrated Breast Cancer Pathway—TP53—glaucoma	2.57e-05	0.00023	CbGpPWpGaD
Mefloquine—ADORA2A—GPCR downstream signaling—EDN1—glaucoma	2.53e-05	0.000227	CbGpPWpGaD
Mefloquine—CYP3A4—Biological oxidations—CYP1B1—glaucoma	2.52e-05	0.000226	CbGpPWpGaD
Mefloquine—CYP3A4—Metapathway biotransformation—CYP1B1—glaucoma	2.48e-05	0.000223	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—NTRK2—glaucoma	2.44e-05	0.000219	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—TXN—glaucoma	2.39e-05	0.000214	CbGpPWpGaD
Mefloquine—ACHE—Metabolism of lipids and lipoproteins—APOE—glaucoma	2.37e-05	0.000213	CbGpPWpGaD
Mefloquine—ACHE—Metabolism of lipids and lipoproteins—CAV1—glaucoma	2.35e-05	0.000211	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—TXN—glaucoma	2.32e-05	0.000208	CbGpPWpGaD
Mefloquine—ABCB1—Allograft Rejection—TNF—glaucoma	2.32e-05	0.000208	CbGpPWpGaD
Mefloquine—ACHE—Integrated Pancreatic Cancer Pathway—TP53—glaucoma	2.32e-05	0.000208	CbGpPWpGaD
Mefloquine—ABCB1—Integrated Pancreatic Cancer Pathway—BAD—glaucoma	2.3e-05	0.000207	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by GPCR—EDN1—glaucoma	2.3e-05	0.000206	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—NARFL—glaucoma	2.21e-05	0.000199	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—CA5A—glaucoma	2.21e-05	0.000199	CbGpPWpGaD
Mefloquine—ADORA2A—GPCR downstream signaling—C3—glaucoma	2.21e-05	0.000199	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism of lipids and lipoproteins—APOE—glaucoma	2.18e-05	0.000196	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism of lipids and lipoproteins—CAV1—glaucoma	2.16e-05	0.000194	CbGpPWpGaD
Mefloquine—ABCB1—Transmembrane transport of small molecules—SLC6A1—glaucoma	2.15e-05	0.000193	CbGpPWpGaD
Mefloquine—ACHE—Metabolism of proteins—MMP1—glaucoma	2.12e-05	0.00019	CbGpPWpGaD
Mefloquine—BCHE—Metabolism of lipids and lipoproteins—APOE—glaucoma	2.12e-05	0.00019	CbGpPWpGaD
Mefloquine—BCHE—Metabolism of lipids and lipoproteins—CAV1—glaucoma	2.1e-05	0.000188	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—NGFR—glaucoma	2.1e-05	0.000188	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—SMO—glaucoma	2.06e-05	0.000185	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—GSTT1—glaucoma	2.02e-05	0.000181	CbGpPWpGaD
Mefloquine—CYP3A4—Biological oxidations—GSTM1—glaucoma	2.01e-05	0.000181	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by GPCR—C3—glaucoma	2.01e-05	0.00018	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—NTRK1—glaucoma	1.99e-05	0.000179	CbGpPWpGaD
Mefloquine—CYP3A4—Metapathway biotransformation—GSTM1—glaucoma	1.99e-05	0.000178	CbGpPWpGaD
Mefloquine—BCHE—Metabolism of proteins—MMP1—glaucoma	1.89e-05	0.000169	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—NTRK2—glaucoma	1.89e-05	0.000169	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—GSTT1—glaucoma	1.85e-05	0.000166	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—CDKN2B—glaucoma	1.83e-05	0.000165	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—GSTT1—glaucoma	1.8e-05	0.000161	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—EDN1—glaucoma	1.76e-05	0.000158	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—CA1—glaucoma	1.76e-05	0.000158	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—CTSA—glaucoma	1.7e-05	0.000153	CbGpPWpGaD
Mefloquine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—glaucoma	1.69e-05	0.000152	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—CA1—glaucoma	1.65e-05	0.000148	CbGpPWpGaD
Mefloquine—ACHE—Metabolism of proteins—MMP2—glaucoma	1.64e-05	0.000147	CbGpPWpGaD
Mefloquine—ACHE—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	1.62e-05	0.000146	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—NGFR—glaucoma	1.62e-05	0.000145	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—NGF—glaucoma	1.62e-05	0.000145	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—CA2—glaucoma	1.61e-05	0.000144	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—ABCA1—glaucoma	1.61e-05	0.000144	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—CYP1B1—glaucoma	1.61e-05	0.000144	CbGpPWpGaD
Mefloquine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—glaucoma	1.6e-05	0.000144	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—CTSA—glaucoma	1.6e-05	0.000144	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—C3—glaucoma	1.54e-05	0.000138	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—NTRK1—glaucoma	1.54e-05	0.000138	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—CA2—glaucoma	1.51e-05	0.000136	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	1.49e-05	0.000134	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—CYP1B1—glaucoma	1.48e-05	0.000132	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—ABCA1—glaucoma	1.48e-05	0.000132	CbGpPWpGaD
Mefloquine—BCHE—Metabolism of proteins—MMP2—glaucoma	1.46e-05	0.000131	CbGpPWpGaD
Mefloquine—BCHE—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	1.45e-05	0.00013	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—ABCA1—glaucoma	1.43e-05	0.000129	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—CYP1B1—glaucoma	1.43e-05	0.000129	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—APOE—glaucoma	1.43e-05	0.000128	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—CAV1—glaucoma	1.42e-05	0.000127	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—CDKN2B—glaucoma	1.42e-05	0.000127	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—EDN1—glaucoma	1.36e-05	0.000122	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—FN1—glaucoma	1.35e-05	0.000121	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—BAD—glaucoma	1.33e-05	0.00012	CbGpPWpGaD
Mefloquine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—glaucoma	1.33e-05	0.00012	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—GSTM1—glaucoma	1.28e-05	0.000115	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—NGF—glaucoma	1.25e-05	0.000112	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—C3—glaucoma	1.19e-05	0.000107	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—GSTM1—glaucoma	1.18e-05	0.000106	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—GSTM1—glaucoma	1.15e-05	0.000103	CbGpPWpGaD
Mefloquine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—glaucoma	1.14e-05	0.000103	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—MTHFR—glaucoma	1.13e-05	0.000102	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—TXN—glaucoma	1.13e-05	0.000101	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—APOE—glaucoma	1.11e-05	9.92e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—CAV1—glaucoma	1.1e-05	9.83e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—CA1—glaucoma	1.08e-05	9.7e-05	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—NOS3—glaucoma	1.07e-05	9.63e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—TXN—glaucoma	1.07e-05	9.56e-05	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—APOE—glaucoma	1.06e-05	9.48e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—CTSA—glaucoma	1.05e-05	9.4e-05	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—CAV1—glaucoma	1.05e-05	9.39e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—FN1—glaucoma	1.04e-05	9.35e-05	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—MTHFR—glaucoma	1.04e-05	9.35e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—BAD—glaucoma	1.03e-05	9.24e-05	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—MTHFR—glaucoma	1.01e-05	9.08e-05	CbGpPWpGaD
Mefloquine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—glaucoma	1.01e-05	9.04e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—CA2—glaucoma	9.89e-06	8.88e-05	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—APOE—glaucoma	9.71e-06	8.71e-05	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—CAV1—glaucoma	9.62e-06	8.63e-05	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—APOE—glaucoma	9.42e-06	8.45e-05	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—CAV1—glaucoma	9.34e-06	8.38e-05	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—CDKN1B—glaucoma	9.29e-06	8.34e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—GSTT1—glaucoma	8.77e-06	7.87e-05	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—MMP9—glaucoma	8.61e-06	7.72e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—NOS3—glaucoma	8.28e-06	7.43e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—GSTT1—glaucoma	8.27e-06	7.42e-05	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—NOS3—glaucoma	7.91e-06	7.1e-05	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—VEGFA—glaucoma	7.73e-06	6.93e-05	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—NOS3—glaucoma	7.27e-06	6.52e-05	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—PTGS2—glaucoma	7.24e-06	6.49e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—CDKN1B—glaucoma	7.18e-06	6.44e-05	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—NOS3—glaucoma	7.06e-06	6.33e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—ABCA1—glaucoma	6.99e-06	6.27e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—CYP1B1—glaucoma	6.99e-06	6.27e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—TXN—glaucoma	6.97e-06	6.25e-05	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—PTGS2—glaucoma	6.65e-06	5.97e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—MMP9—glaucoma	6.65e-06	5.96e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—ABCA1—glaucoma	6.59e-06	5.91e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—CYP1B1—glaucoma	6.59e-06	5.91e-05	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—PTGS2—glaucoma	6.46e-06	5.79e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—VEGFA—glaucoma	5.97e-06	5.35e-05	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—TP53—glaucoma	5.84e-06	5.24e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—GSTM1—glaucoma	5.59e-06	5.01e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—GSTT1—glaucoma	5.4e-06	4.85e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—GSTM1—glaucoma	5.27e-06	4.72e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—MTHFR—glaucoma	4.94e-06	4.43e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—MTHFR—glaucoma	4.65e-06	4.17e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—APOE—glaucoma	4.6e-06	4.12e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—CAV1—glaucoma	4.55e-06	4.09e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—TP53—glaucoma	4.51e-06	4.05e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—APOE—glaucoma	4.33e-06	3.89e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—CYP1B1—glaucoma	4.31e-06	3.86e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—ABCA1—glaucoma	4.31e-06	3.86e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—CAV1—glaucoma	4.29e-06	3.85e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—NOS3—glaucoma	3.44e-06	3.09e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—GSTM1—glaucoma	3.44e-06	3.09e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—NOS3—glaucoma	3.25e-06	2.91e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—PTGS2—glaucoma	3.15e-06	2.83e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—MTHFR—glaucoma	3.04e-06	2.73e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—PTGS2—glaucoma	2.97e-06	2.66e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—APOE—glaucoma	2.83e-06	2.54e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—CAV1—glaucoma	2.81e-06	2.52e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—NOS3—glaucoma	2.12e-06	1.9e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—PTGS2—glaucoma	1.94e-06	1.74e-05	CbGpPWpGaD
